| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From the Institut de Biologie et Chimie des
Protéines,*
Centre National de la Recherche
Scientifique, Lyon, France; the Departamento de Histologia e
Embriologia,
Universidade do Estado do Rio de
Janeiro, Rio de Janeiro, Brazil; the Service Commun de Microscopie
Électronique,
Faculté de
Médecine Laënnec, Lyon, France; the Centre des
Brûlés,§
Chirurgie
Réparatrice, Centre Hospitalier St. Joseph et St. Luc, Lyon,
France; and the Groupe de Recherches pour lEtude du
Foie,¶
Institut National de la Santé
et de la Recherche Médicale, Université Victor Segalen,
Bordeaux, France
| Abstract |
|---|
|
|
|---|
-Smooth
muscle actin-expressing myofibroblasts were absent in normal
skin, present in large amounts in non-pressure-treated
regions, and almost absent in pressure-treated regions. The
disturbed ultrastructural organization of dermal-epidermal junction
observed in non-pressure-treated regions disappeared after pressure
therapy; typical features of apoptosis in fibroblastic cells and
morphological aspects of collagen degradation were observed in
pressure-treated regions. Our results show that, in
hypertrophic scars, pressure therapy restores in part the
extracellular matrix organization observed in normal scar and induces
the disappearance of
-smooth muscle actin-expressing
myofibroblasts, probably by apoptosis. We suggest that the
pressure acts by accelerating the remission phase of the postburn
reparative process.
| Introduction |
|---|
|
|
|---|
-smooth muscle (SM)
actin-expressing myofibroblasts and thin, randomly organized collagen
fibers, both usually arranged in nodules.2
Myofibroblasts, which are the main cellular type observed in
granulation tissue, are modified fibroblasts that present some features
typical of SM cells.3
They contain bundles of
microfilaments with dense bodies similar to those found in SM cells and
can express, depending on situations, specific cytoskeletal proteins
including
-SM actin, desmin, and SM myosin heavy
chains.4
These features suggest that myofibroblasts are
responsible for the force determining wound contraction5
and for the pathological contractures observed in hypertrophic
scars.2,6
In the normal healing process, after re-epithelialization, the decrease in cellularity during the transition between granulation tissue and scar is mediated by apoptosis and an impressive remodeling of the extracellular matrix occurs.7 During excessive scarring, the mechanisms involved in normal scar formation do not occur; the granulation tissue does not regress and the cells, particularly the myofibroblasts, are continually activated and producing extracellular matrix. Although some hypertrophic scars may spontaneously regress, others remain active for years.8 Of all of the treatments available, pressure exerted with elastic bandages in such a manner that the enforced pressure (24 mm Hg) exceeds the inherent capillary pressure gives significant results.9 Although it is an efficient method, its exact mechanisms of action are not known. Previous studies concerning pressure-treated hypertrophic scars have focused mainly on the role of hypoxia. It has been shown that granulation tissue is oxygen-poor, a condition which could stimulate fibroblast proliferation and collagen production.10 It has been suggested that the application of pressure increases an already present condition of hypoxia, resulting in resolution of the scar.11,12
Extracellular matrix components are involved in growth, differentiation, migration, and death of many different cellular types. During wound healing, the pattern of expression of the extracellular matrix components is different from that usually present in normal skin,13 and various extracellular matrix components play significant roles in the different stages of wound healing. Among extracellular matrix components, some of them participate in skin resistance (eg, collagens), whereas others allow skin elasticity (eg, elastin). In the context of hypertrophic scars, which show a high tendency to develop contractures, the study of the elastic system is relevant. The elastic system is formed by three types of fibers: oxytalan, elaunin, and elastic.14 The oxytalan fibers are formed exclusively by microfibrils, the elaunin fibers by microfibrils and patches of amorphous material (elastin), and the elastic fibers by a large amount of elastin with microfibrils.14 In a recent study, it was shown that elastin and fibrillin (a component of microfibrils) are present 7 days after injury in human experimental full-thickness wounds,15 showing that elastic system fibers are present in the early phases of wound healing. However, few data concerning the detailed organization of elastic system fibers in scars are available.16-18 Among other components of extracellular matrix present in dermis, glycoproteins such as tenascin are suggested to play an important role in wound healing.19 Tenascin is a glycoprotein sparsely distributed in normal skin, predominantly associated with basal laminas.20 In early phases of wound healing and during the formation of granulation tissue, there is a marked increase in expression of tenascin, but tenascin returns to normal levels after the end of wound contraction.19,21
In the present study, we investigated by histochemistry and
immunohistochemistry the expression and organization of extracellular
matrix components, including fibrillin, elastin, and tenascin, and the
distribution of
-SM actin-expressing myofibroblasts in
non-pressure-treated and pressure-treated hypertrophic scars. We also
evaluated by transmission electron microscopy the dermal-epidermal
junction modifications and the presence of apoptotic features during
the pressure-induced scar remodeling.
| Materials and Methods |
|---|
|
|
|---|
Nine patients were included in this study. Their ages ranged from
18 to 54 years (average 32.7 years) and they included one woman (Table 1)
. All patients had hypertrophic scars
that arose after burn injuries. The clinical diagnosis of hypertrophic
scar was done based on the standard clinical criteria as described by
Sahl and Clever,22
such as elevation above the skin
surface limited to injury borders, redness, and itching. The age of
scars at the beginning of the treatment ranged from 3 to 11 months
(average 7 months) and all these scars showed criteria of active
hypertrophic scars.22
The biopsies were taken 2 to 7
months (average 4.1 months) after the beginning of the pressure
treatment. Each patient had two 3-mm punch biopsies, one in the
pressure-treated region and the other in an adjacent,
non-pressure-treated region. The distance between the two biopsies was
about 7 cm and we can exclude an effect between non-pressure- and the
neighboring pressure-treated biopsy site. Normal skin biopsies from
three mammaplasties were used as controls. Tissue samples were fixed in
Bouins liquid and embedded in paraffin, cryopreserved in OCT compound
(Sakura, Torrance, CA) and snap-frozen in liquid nitrogen, or fixed in
2% glutaraldehyde/0.1 mol/L Na-cacodylate/HCl, pH 7.4,
postfixed in 1% osmium tetroxide/0.15 mol/L Na-cacodylate/HCl, pH 7.4,
and embedded in Epon. The size of the biopsies obtained from burn
patients was obviously limited and did not allow the use of other
analytical methods (eg, biochemical).
|
Histology and Immunohistochemistry
Tissue sections of material embedded in paraffin (5 µm) were stained with hematoxylin-eosin, Gomoris silver impregnation, or orcein. The Gomoris silver impregnation contrasted reticular collagen fibers present in the dermis and the orcein staining pointed out the elastic fibers.
Cryostat sections (6 µm) were labeled using the following primary
antibodies: a mouse monoclonal anti-human fibrillin-1 (Neomarkers,
Fremont, CA), a rabbit polyclonal anti-human elastin (Institut Pasteur
de Lyon, Lyon, France), a mouse monoclonal anti-human tenascin (Sigma,
St. Louis, MO), a rabbit polyclonal anti-human laminin (Institut
Pasteur de Lyon), a rabbit polyclonal anti-human type IV collagen
(Institut Pasteur de Lyon), a mouse monoclonal anti-human type VII
collagen (Gibco BRL, Gaithersburg, MD), and a mouse monoclonal
anti-
-SM actin.23
These antibodies have been previously
well characterized, are very specific, and have been used extensively
in other experimental and clinical conditions. The secondary antibodies
were cyanine 3-conjugated goat anti-mouse IgG (Jackson Immunoresearch
Lab, West Grove, PA) or fluorescein-conjugated goat anti-rabbit IgG
(Jackson Immunoresearch). The sections were examined in a Leitz
Laborlux S microscope (Wild-Leitz, Heerbrugg, Switzerland) equipped
with epi-illumination and specific filters for fluorescein and cyanine
3.
The histological grading system used for
-SM actin immunostaining
was: 0, expression of
-SM actin only in vessels; 1+, discreet; 2+,
moderate; and 3+, impressive amount of myofibroblasts expressing
-SM
actin. The nonparametric Mann-Whitney test was used to compare the
scores in non-pressure-treated and pressure-treated regions.
Morphometry
Epidermis thickness was evaluated in hematoxylin-eosin stained sections, using a computerized image analysis system (Histo 200; Biocom, Les Ullis, France). The station included an Ortoplan photomicroscope (Wild-Leitz), a CCD camera (WV-CD 52; Panasonic, Osaka, Japan), and a Pentium Biocom S/X computer (Biocom). Ten measurements were taken for each field, and five fields were analyzed in each biopsy using a 20x objective. The slides were evaluated blindly by two independent observers and no difference was found in their data. Results are presented as mean ± SD. The two different conditions (non-pressure-treated or pressure-treated) were compared using Students t-test, and the result was considered statistically significant when P < 0.05.
Transmission Electron Microscopy
Semithin sections were stained with toluidine blue. Thin sections were contrasted with methanolic solution of uranyl acetate and lead citrate and observed with a Philips CM120 transmission electron microscope (Philips SA, Zurich, Switzerland).
| Results |
|---|
|
|
|---|
The presence of inflammation was not impressive in any biopsy. In non-pressure-treated regions, the epidermis thickness (130.5 ± 35.5 µm) was increased compared with pressure-treated regions (106.9 ± 26.8 µm; P < 0.01); furthermore, the epidermis in both non-pressure- and pressure-treated regions was thicker compared with normal skin (44.8 ± 17.5 µm).
In the dermis, non-pressure-treated regions showed the typical organization of hypertrophic scar with an important cellularity and numerous vessels surrounding nodule-like structures as previously described.24 In non-pressure-treated regions, the classical dermal/epidermal interface characterized by prominent elongated rete ridge was not observed. In both non-pressure-treated and pressure-treated regions, it was not possible to define the papillary and the reticular dermis. In pressure-treated regions, the number of vessels was reduced compared with non-pressure-treated regions. Furthermore, in non-pressure-treated regions, the vessels were localized mainly in superficial dermis, whereas in pressure-treated regions most vessels were localized in the deep dermis, as in normal skin.
In normal skin, Gomoris silver impregnation showed that reticular
collagen fibers were randomly organized in the dermis without forming
bundles (data not shown). In the non-pressure-treated regions, some
bundles of reticular collagen fibers anchored perpendicular to the
dermal-epidermal junction (Figure 1a)
. By
contrast, in the pressure-treated regions the reticular collagen fibers
were thinner, with an arrangement rather parallel to skin surface
(Figure 1b)
, thus resembling normal skin.
|
Immunofluorescence Staining
The results of the immunofluorescence study are summarized in
Table 2
. Using antibodies against
fibrillin and elastin, the detailed organization of the elastic system
fibers was studied. In normal skin, fibrillin of the papillary dermis
was present in brushlike fibers inserted into the basal lamina
(oxytalan fibers), showing the so-called candelabra-like configuration;
more deeply, thicker fibers were observed, continuous with the
superficial ones, thus forming a fibrillin network (Figure 2a)
. In non-pressure-treated regions,
fibrillin arrangement was disturbed. In the superficial dermis, the
candelabra-like pattern disappeared and the amount of fibrillin was
reduced compared with normal skin or with pressure-treated regions; in
the deep dermis, discreet fibrillin deposits resembled fragmented
fibers (Figure 2b)
. In the pressure-treated regions, the fibers
localized under the dermal-epidermal region were better organized
compared with non-pressure-treated regions. However, they were thicker
than normal ones and the typical candelabra-like pattern was not
completely restored; in deep dermis fibrillin deposits were nearly
normal although the fibers looked smaller (Figure 2c)
. In normal skin,
elastin was absent in the oxytalan fiber region, beneath epidermis, and
was present as long aggregates forming fibers arranged mainly
horizontally in the dermis (Figure 2d)
. In non-pressure-treated
regions, elastin was present in patch deposits, not forming fibers
(Figure 2e)
. In pressure-treated regions, some elastin was observed in
the superficial dermis near the dermal-epidermal junction; the fibers
were shorter and thinner compared with normal dermis (Figure 2f)
.
|
|
|
In normal skin,
-SM actin was observed exclusively in vessels. In
non-pressure-treated regions, the proportion of
-SM actin-expressing
myofibroblasts was impressive (average 3+) and localized mainly in
nodules (Figure 4a)
, as previously
described.2
In contrast, pressure-treated regions
exhibited a marked and significant decrease of
-SM actin-expressing
myofibroblasts (average 0, P < 0.01, Figure 4b
).
|
The results of the transmission electron microscopy analysis are
summarized in Table 3
. Significant
morphological changes were observed within the dermal-epidermal
junction. In normal skin, the typical organization of subepithelial
basal lamina (lamina lucida and lamina densa) accompanying the
microfoot processes of the keratinocytes, and regularly distributed
hemidesmosomes and anchoring filaments and fibrils, as described by
McMillan et al,25
were observed (Figure 5a)
. In non-pressure-treated regions
(Figure 5b)
, the dermal-epidermal junction was smooth and the
keratinocyte microfoot processes were almost absent. The lamina densa
was thickened and the lamina lucida was not clearly defined. The
hemidesmosomes and the anchoring fibrils were not regularly
distributed. Furthermore, the outer plaque of hemidesmosomes was not
well delimited and the subbasal dense plate was missing; moreover,
anchoring fibrils were thicker compared with those observed in normal
skin or in pressure-treated regions. Collagen fibers immediately
beneath the lamina densa were frequently observed. In pressure-treated
regions, the dermal-epidermal junction resembled that observed in
normal skin with well organized hemidesmosomes; however, the depth of
keratinocyte microfoot processes was increased (Figure 5c)
compared
with normal skin.
|
|
|
Typical myofibroblasts were observed in non-pressure-treated regions,
with long processes containing microfilament bundles and
extending for long distances among collagen fiber bundles as previously
described.12
In pressure-treated regions, the proportion
of cells showing myofibroblastic features was reduced. Furthermore,
numerous fibroblastic cells presenting apoptotic features were observed
(Figure 6, c and d)
. The main criteria used for the identification of
apoptotic cells were vesiculation, condensation and margination of the
chromatin, fragmentation of the nucleus, and cytoplasmic condensation.
As previously described in myofibroblasts undergoing apoptosis during
granulation tissue remodeling,7
nuclei in part extruded
from the cytoplasm were frequently observed (Figure 6, c and d)
.
| Discussion |
|---|
|
|
|---|
The elastic system fibers are not frequently considered in the studies of skin wound healing.29 Early studies using histochemical techniques described the presence of elastic fibers only in late phases of wound healing.17 Using similar techniques, Bhangoo et al16 showed the presence of elastic fibers in different types of human scars (atrophic, normal, hypertrophic, and keloid) that were at least 1 year old. They observed that elastic fibers in hypertrophic scars had a disturbed arrangement and were localized mainly in superficial layers of the scar; in deep regions the distribution was patchy and some areas were entirely devoid of elastic fibers. However, more recent studies using transmission electron microscopy and immunohistochemistry showed the presence of some elastic system fiber components, fibrillin and elastin, also in early phases of wound healing in skin and liver.15,30,31 To our knowledge the present study is the first to show the presence of fibrillin and elastin and to describe their organization in hypertrophic scars. Fleischmajer et al,32 studying another skin fibrotic disease, scleroderma, observed an increase in deposition of microfibrils, but not of elastin, in deep dermis. In the present study we showed the presence of both components (fibrillin and elastin) in hypertrophic scars without major alterations in amount when compared with normal skin, but with important disorders in organization. Those alterations may be associated with an elastic system still immature as described by Tsuji and Sawabe.18 The pressure treatment allowed a rearrangement of fibrillin and elastin, with acquisition of an almost normal pattern enabling those fibers to carry out their physiological functions as in normal dermis. This may explain the softness in scars acquired as a consequence of pressure treatment.
During normal wound healing tenascin is abundant in granulation tissue but disappears soon after re-epithelialization.19 Our findings showing an impressive accumulation of tenascin in non-pressure-treated regions support the hypothesis that hypertrophic scars develop as a consequence of an excessive process of healing. In pressure-treated regions, as in normal skin, tenascin was present in dermal papilla and in basal lamina of vessels. Little is known about the function of tenascin in wound healing. However, Mackie et al19 have suggested that the presence of tenascin allows myofibroblasts to contract the wound; in the case of hypertrophic scars, the continual presence of tenascin may contribute to the development of contractures.
Modifications of dermal-epidermal junction have been observed in different diseases, particularly in junctional forms of epidermolysis bullosa.25 Here, we observed that hypertrophic scars presented a disorganized dermal-epidermal junction, and that after pressure treatment there is a marked improvement in this ultrastructural organization. Among the changes observed as a consequence of pressure, the hemidesmosomes were found to have the normal ultrastructure and a regular distribution; and the keratinocyte microfoot processes became more elongated forming pseudopodia-like extensions as described by Mommaas et al.33 The presence of these long extensions probably compensates for the absence of a normal rete ridge pattern and increases the dermal-epidermal interface and attachment. Futhermore, the differences observed by transmission electron microscopy in the organization of the dermal-epidermal junction between normal skin, non-pressure-treated, and pressure-treated regions suggest subtle modifications in the organization of anchoring fibrils, although immunofluorescence did not show changes of the type IV and type VII collagen distribution.
The extracellular matrix reorganization, which also involves collagen degradation, together with the disappearance of myofibroblasts, may explain the improvements obtained with pressure in mechanical properties of the scar. We suggest that pressure induces the decrease in cellularity similar to that observed in the final stages of normal wound healing, where apoptosis is the mechanism through which vascular and fibroblastic cells are gradually eliminated.7 We failed to demonstrate a significant proportion of apoptotic cells by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) technique,34 probably because pressure-induced apoptosis affects target cells consecutively rather than producing a single wave of cell disappearance.
The mechanism of action of pressure is not known. Kischer et al11 suggested that hypoxia, which causes hypertrophic scarring, is increased by pressure and causes the resolution of scar by induction of fibroblast death. Baur et al28 disagreed and suggested that the treatment causes an increase in collagenase activity and a consequent increase in extracellular matrix degradation. It is known that mechanical forces induce modifications in extracellular matrix organization and composition in different situations such as development35 or cholestatic fibrosis.31 Furthermore, changes in environmental mechanical forces modulate the expression of matrix remodeling enzymes36 and induce apoptosis in dermal fibroblasts cultured in three-dimensional collagen gels.37 These modifications affect the mechanical properties of involved tissues as well as the cells present in these tissues.
In conclusion, in this study, we used immunofluorescence to observe the
modifications of fibrillin, elastin, tenascin, and
-SM actin
expression and electron microscopy to observe the changes of
dermal-epidermal junction in human pressure versus
non-pressure-treated hypertrophic scars. We suggest that the treatment
of postburn hypertrophic scars by pressure induces extracellular matrix
reorganization and apoptosis in fibrogenic (ie, myofibroblasts) and
vascular cells. Further studies are necessary to clarify the mechanisms
of mechanosignal transduction involved in extracellular matrix
remodeling and cell death resulting in hypertrophic scar resolution.
| Acknowledgements |
|---|
Parts of this study were presented to the Seventh Annual Meeting of the Wound Healing Society (Nashville, TN, 1997).
| Footnotes |
|---|
Supported in part by a Projet Hospitalier de Recherche Clinique 1995 (Centre Hospitalier Saint-Joseph et Saint-Luc, Lyon, France).
Accepted for publication July 15, 1999.
| References |
|---|
|
|
|---|
-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986, 103:2787-2796This article has been cited by other articles:
![]() |
C. H. Liu, Z. You, J. Ren, Y. R. Kim, K. Eikermann-Haerter, and P. K. Liu Noninvasive delivery of gene targeting probes to live brains for transcription MRI FASEB J, April 1, 2008; 22(4): 1193 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Cardoso, B. R. Souza, T. P. Amadeu, S. S. Valenca, L. C. M. S. Porto, and A. M. A. Costa Effects of Cigarette Smoke in Mice Wound Healing is Strain Dependent Toxicol Pathol, December 1, 2007; 35(7): 890 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aarabi, K. A. Bhatt, Y. Shi, J. Paterno, E. I. Chang, S. A. Loh, J. W. Holmes, M. T. Longaker, H. Yee, and G. C. Gurtner Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis FASEB J, October 1, 2007; 21(12): 3250 - 3261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mukhopadhyay, S. Y. Chan, I. J. Lim, D. J. Phillips, and T. T. Phan The role of the activin system in keloid pathogenesis Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1331 - C1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Rai, K. Tripathi, D. Sharma, and V. K. Shukla Apoptosis: A Basic Physiologic Process in Wound Healing International Journal of Lower Extremity Wounds, September 1, 2005; 4(3): 138 - 144. [Abstract] [PDF] |
||||
![]() |
T. A. H. Jarvinen, L. Jozsa, P. Kannus, T. L. N. Jarvinen, T. Hurme, M. Kvist, M. Pelto-Huikko, H. Kalimo, and M. Jarvinen Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle J. Cell Sci., March 1, 2003; 116(5): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Reno, P. Grazianetti, M. Stella, G. Magliacani, C. Pezzuto, and M. Cannas Release and Activation of Matrix Metalloproteinase-9 During In Vitro Mechanical Compression in Hypertrophic Scars Arch Dermatol, April 1, 2002; 138(4): 475 - 478. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |